210 related articles for article (PubMed ID: 36593955)
1. Size-advantage of monovalent nanobodies against the macrophage mannose receptor for deep tumor penetration and tumor-associated macrophage targeting.
Erreni M; D'Autilia F; Avigni R; Bolli E; Arnouk SM; Movahedi K; Debie P; Anselmo A; Parente R; Vincke C; van Leeuwen FWB; Allavena P; Garlanda C; Mantovani A; Doni A; Hernot S; Van Ginderachter JA
Theranostics; 2023; 13(1):355-373. PubMed ID: 36593955
[No Abstract] [Full Text] [Related]
2. Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages.
Movahedi K; Schoonooghe S; Laoui D; Houbracken I; Waelput W; Breckpot K; Bouwens L; Lahoutte T; De Baetselier P; Raes G; Devoogdt N; Van Ginderachter JA
Cancer Res; 2012 Aug; 72(16):4165-77. PubMed ID: 22719068
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of [
Bala G; Baudhuin H; Remory I; Gillis K; Debie P; Krasniqi A; Lahoutte T; Raes G; Devoogdt N; Cosyns B; Hernot S
Mol Imaging Biol; 2018 Apr; 20(2):260-267. PubMed ID: 28875290
[TBL] [Abstract][Full Text] [Related]
4. Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumors.
Bolli E; D'Huyvetter M; Murgaski A; Berus D; Stangé G; Clappaert EJ; Arnouk S; Pombo Antunes AR; Krasniqi A; Lahoutte T; Gonçalves A; Vuylsteke M; Raes G; Devoogdt N; Movahedi K; Van Ginderachter JA
J Control Release; 2019 Nov; 314():1-11. PubMed ID: 31626860
[TBL] [Abstract][Full Text] [Related]
5. Single-domain antibody fusion proteins can target and shuttle functional proteins into macrophage mannose receptor expressing macrophages.
De Vlaeminck Y; Lecocq Q; Giron P; Heirman C; Geeraerts X; Bolli E; Movahedi K; Massa S; Schoonooghe S; Thielemans K; Goyvaerts C; Van Ginderachter JA; Breckpot K
J Control Release; 2019 Apr; 299():107-120. PubMed ID: 30797866
[TBL] [Abstract][Full Text] [Related]
6. PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments.
Blykers A; Schoonooghe S; Xavier C; D'hoe K; Laoui D; D'Huyvetter M; Vaneycken I; Cleeren F; Bormans G; Heemskerk J; Raes G; De Baetselier P; Lahoutte T; Devoogdt N; Van Ginderachter JA; Caveliers V
J Nucl Med; 2015 Aug; 56(8):1265-71. PubMed ID: 26069306
[TBL] [Abstract][Full Text] [Related]
7. SPECT imaging of joint inflammation with Nanobodies targeting the macrophage mannose receptor in a mouse model for rheumatoid arthritis.
Put S; Schoonooghe S; Devoogdt N; Schurgers E; Avau A; Mitera T; D'Huyvetter M; De Baetselier P; Raes G; Lahoutte T; Matthys P
J Nucl Med; 2013 May; 54(5):807-14. PubMed ID: 23447654
[TBL] [Abstract][Full Text] [Related]
8. Clinical Translation of [
Xavier C; Blykers A; Laoui D; Bolli E; Vaneyken I; Bridoux J; Baudhuin H; Raes G; Everaert H; Movahedi K; Van Ginderachter JA; Devoogdt N; Caveliers V; Lahoutte T; Keyaerts M
Mol Imaging Biol; 2019 Oct; 21(5):898-906. PubMed ID: 30671739
[TBL] [Abstract][Full Text] [Related]
9. Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumours.
Debie P; Lafont C; Defrise M; Hansen I; van Willigen DM; van Leeuwen FWB; Gijsbers R; D'Huyvetter M; Devoogdt N; Lahoutte T; Mollard P; Hernot S
J Control Release; 2020 Jan; 317():34-42. PubMed ID: 31734445
[TBL] [Abstract][Full Text] [Related]
10. Targeting Protumoral Tumor-Associated Macrophages with Nanobody-Functionalized Nanogels through Strain Promoted Azide Alkyne Cycloaddition Ligation.
Nuhn L; Bolli E; Massa S; Vandenberghe I; Movahedi K; Devreese B; Van Ginderachter JA; De Geest BG
Bioconjug Chem; 2018 Jul; 29(7):2394-2405. PubMed ID: 29889515
[TBL] [Abstract][Full Text] [Related]
11. Mannose receptor (MR) engagement by mesothelin GPI anchor polarizes tumor-associated macrophages and is blocked by anti-MR human recombinant antibody.
Dangaj D; Abbott KL; Mookerjee A; Zhao A; Kirby PS; Sandaltzopoulos R; Powell DJ; Lamazière A; Siegel DL; Wolf C; Scholler N
PLoS One; 2011; 6(12):e28386. PubMed ID: 22163010
[TBL] [Abstract][Full Text] [Related]
12. Targeting Pro-Tumoral Macrophages in Early Primary and Metastatic Breast Tumors with the CD206-Binding mUNO Peptide.
Lepland A; Asciutto EK; Malfanti A; Simón-Gracia L; Sidorenko V; Vicent MJ; Teesalu T; Scodeller P
Mol Pharm; 2020 Jul; 17(7):2518-2531. PubMed ID: 32421341
[TBL] [Abstract][Full Text] [Related]
13. Targeted Repolarization of Tumor-Associated Macrophages via Imidazoquinoline-Linked Nanobodies.
Bolli E; Scherger M; Arnouk SM; Pombo Antunes AR; Straßburger D; Urschbach M; Stickdorn J; De Vlaminck K; Movahedi K; Räder HJ; Hernot S; Besenius P; Van Ginderachter JA; Nuhn L
Adv Sci (Weinh); 2021 May; 8(10):2004574. PubMed ID: 34026453
[TBL] [Abstract][Full Text] [Related]
14. Monitoring liver macrophages using nanobodies targeting Vsig4: concanavalin A induced acute hepatitis as paradigm.
Zheng F; Devoogdt N; Sparkes A; Morias Y; Abels C; Stijlemans B; Lahoutte T; Muyldermans S; De Baetselier P; Schoonooghe S; Beschin A; Raes G
Immunobiology; 2015 Feb; 220(2):200-9. PubMed ID: 25440182
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity Risk Profile of Nanobodies.
Ackaert C; Smiejkowska N; Xavier C; Sterckx YGJ; Denies S; Stijlemans B; Elkrim Y; Devoogdt N; Caveliers V; Lahoutte T; Muyldermans S; Breckpot K; Keyaerts M
Front Immunol; 2021; 12():632687. PubMed ID: 33767701
[TBL] [Abstract][Full Text] [Related]
16. Biotherapeutic target or sink: analysis of the macrophage mannose receptor tissue distribution in murine models of lysosomal storage diseases.
Zhang XS; Brondyk W; Lydon JT; Thurberg BL; Piepenhagen PA
J Inherit Metab Dis; 2011 Jun; 34(3):795-809. PubMed ID: 21416197
[TBL] [Abstract][Full Text] [Related]
17. Imaging of Tumor Spheroids, Dual-Isotope SPECT, and Autoradiographic Analysis to Assess the Tumor Uptake and Distribution of Different Nanobodies.
Beltrán Hernández I; Rompen R; Rossin R; Xenaki KT; Katrukha EA; Nicolay K; van Bergen En Henegouwen P; Grüll H; Oliveira S
Mol Imaging Biol; 2019 Dec; 21(6):1079-1088. PubMed ID: 30859470
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E specifically upregulates the expression of the mannose-receptor on mouse bone marrow-derived macrophages.
Schreiber S; Blum JS; Chappel JC; Stenson WF; Stahl PD; Teitelbaum SL; Perkins SL
Cell Regul; 1990 Apr; 1(5):403-13. PubMed ID: 1965946
[TBL] [Abstract][Full Text] [Related]
19. Macrophage receptors for influenza A virus: role of the macrophage galactose-type lectin and mannose receptor in viral entry.
Upham JP; Pickett D; Irimura T; Anders EM; Reading PC
J Virol; 2010 Apr; 84(8):3730-7. PubMed ID: 20106926
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
